These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27400293)

  • 1. Optical coherence tomography guided treatment of recurrent drug-eluting stent failure using drug-eluting balloon.
    Latsios G; Karanasos A; Toutouzas K; Vogiatzi G; Papaioannou S; Synetos A; Tousoulis D
    Int J Cardiol; 2016 Oct; 221():32-3. PubMed ID: 27400293
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty.
    Suzuki S; Nakatani S; Sotomi Y; Shiojima I; Sakata Y; Higuchi Y
    J Int Med Res; 2020 Jan; 48(1):300060519837445. PubMed ID: 30938569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-eluting balloon in the treatment of a recurrent in-stent restenosis of drug-eluting stent].
    Merkely B; Jambrik Z
    Orv Hetil; 2010 Sep; 151(37):1509-14. PubMed ID: 20807698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D optical coherence tomography: new insights into the process of optimal rewiring of side branches during bifurcational stenting.
    Okamura T; Onuma Y; Yamada J; Iqbal J; Tateishi H; Nao T; Oda T; Maeda T; Nakamura T; Miura T; Yano M; Serruys PW
    EuroIntervention; 2014 Dec; 10(8):907-15. PubMed ID: 24531393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of stent strut coverage following angiography- or optical coherence tomography-guided percutaneous coronary intervention.
    Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):190-7. PubMed ID: 25487222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel crystals on the surface of a bioresorbable vascular scaffold visualized by optical coherence tomography after drug-eluting balloon angioplasty.
    López-Benito M; Pérez de Prado A; Cuellas C; Estévez R; Fernández-Vázquez F
    Eur Heart J Cardiovasc Imaging; 2017 Jun; 18(6):638. PubMed ID: 28329070
    [No Abstract]   [Full Text] [Related]  

  • 10. Stent deformation at the edge of a high pressure balloon.
    Kilic ID; Foin N; Konstantinidis N; Serdoz R; Caiazzo G; Di Mario C
    Cardiovasc Revasc Med; 2015 Dec; 16(8):508-9. PubMed ID: 25819072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography to diagnose under-expansion of a drug-eluting stent.
    Motreff P; Souteyrand G
    JACC Cardiovasc Imaging; 2009 Feb; 2(2):245-6; author reply 246. PubMed ID: 19356563
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-coated balloon for recurrent in-stent restenosis treatment: A suitable strategy.
    Piraino D; Buccheri D; Cimino G; Andolina G
    Int J Cardiol; 2016 Oct; 221():1084-6. PubMed ID: 27448537
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.
    Tada T; Kadota K; Hosogi S; Miyake K; Amano H; Nakamura M; Izawa Y; Kubo S; Ichinohe T; Hyoudou Y; Eguchi H; Hayakawa Y; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tanaka H; Fuku Y; Kato H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):307-15. PubMed ID: 24042176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial.
    Byrne RA; Neumann FJ; Mehilli J; Pinieck S; Wolff B; Tiroch K; Schulz S; Fusaro M; Ott I; Ibrahim T; Hausleiter J; Valina C; Pache J; Laugwitz KL; Massberg S; Kastrati A;
    Lancet; 2013 Feb; 381(9865):461-7. PubMed ID: 23206837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of fragmented balloon materials in coronary arteries by optical coherence tomography.
    Adoni NA; Huang GW; Rangasetty UC; Gilani S; Fujise K
    JACC Cardiovasc Interv; 2014 Jun; 7(6):e65-6. PubMed ID: 24947730
    [No Abstract]   [Full Text] [Related]  

  • 17. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
    Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
    Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and distribution of thin-high signals detected by coronary optical coherence tomography in patients treated with paclitaxel-coated balloon angioplasty for in-stent restenosis.
    Kawashima H; Suzuki N; Kyono H; Mitsui M; Okabe S; Watanabe Y; Ishikawa S; Kozuma K
    Int J Cardiol; 2016 Jan; 202():892-3. PubMed ID: 26476988
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiographically silent very late stent thrombosis detected by optical coherence tomography in association with peri-stent staining and multiple interstrut cavities.
    Cassar A; Gulati R; Matsuo Y; Bresnahan JF; Prasad A
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):603. PubMed ID: 23258315
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-coated balloon without stent implantation for chronic total occlusion of coronary arteries: Description of a new strategy with an optical coherence tomography assistance.
    Cortese B; Buccheri D; Piraino D; Silva-Orrego P
    Int J Cardiol; 2015 Jul; 191():75-6. PubMed ID: 25965604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.